TP53 and neuroblastoma: For example, de novo somatic TP53 mutations are uncommon in Western series of neuroblastoma (33), but polymorphisms such as R72P R337H are more frequent in non-Caucasian populations and are associated with varying incidence of neuroblastoma (39, 40).